950 — Lees Pharmaceutical Holdings Share News
0.000.00%
Last trade - 00:00- HK$624.17m
- HK$438.96m
- HK$1.44bn
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA
Brief: Lee's Pharmaceutical Receives FDA Approval Of Supplemental New Drug Application For Adasuve
Brief: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform And Assets, Driving Pipeline Expansion And Advancing Global Partnership With UCB Through Acquired Rights
Brief: Lee's Pharmaceutical Says Unit Buys Assets For US$15 Million
Brief: Lee's Pharmaceutical Says Socazolimab Approved For Marketing By NMPA
Brief: Lee's Pharmaceutical Sees Profit Between HK$83 Million To HK$106 Million For Year
Brief: Lee's Pharmaceutical Says Unit Entered Compensation Agreement For State-Owned Land
Brief: Lee's Pharmaceutical Says NMPA Accepted Application For Clinical Trial Of Recombinant Anfibatide Injection
Brief: Lee's Pharmaceutical Says Drug Registration Certificate For Adasuve Obtained From China NMPA
Brief: Lee's Pharmaceutical Announces Disposal Of Assets
Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between Hk$12 Mln & Hk$17 Mln For Six Months
Brief: Lee's Pharmaceutical Says Apremilast Tablet Obtains Drug Registration Certificate
Brief: Lee's Pharmaceutical Says Got Medical Device Registration Certificate For Inomax Dsir Plus Delivery System
Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between HK$40 And HK$90Mln For Year
Brief: Lee's Pharmaceutical Announces Inclusion Of Treprostinil Injection, Teglutik And Trittico In NRDL
Brief: Lee's Pharmaceutical Reports Qtrly Profit Attributable HK$34.2 Mln